You are currently on the new version of our website. Access the old version .

Cancers, Volume 10, Issue 7

July 2018 - 31 articles

Cover Story: Oncoviruses are capable of subverting the cell signaling machinery and metabolic pathways and exploit them for infection, replication, and persistence. Some viral oncoproteins are able to directly bind to and degrade p53, others cause the functionally inactivation of the oncosuppressor and deregulated expression of many genes orchestrated by p53. New drugs are being developed to target the interaction between viral oncoproteins and p53, as well as the negative regulators MDM2/MDMX and p53, and are already at the preclinical study stage and early-phase clinical trials. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (31)

  • Review
  • Open Access
10 Citations
6,055 Views
17 Pages

29 June 2018

It has been widely shown that the focal adhesion kinase (FAK) is involved in nearly every aspect of cancer, from invasion to metastasis to epithelial–mesenchymal transition and maintenance of cancer stem cells. FAK has been shown to interact wi...

  • Article
  • Open Access
29 Citations
6,210 Views
13 Pages

Nano-Pulse Stimulation for the Treatment of Pancreatic Cancer and the Changes in Immune Profile

  • Siqi Guo,
  • Niculina I. Burcus,
  • James Hornef,
  • Yu Jing,
  • Chunqi Jiang,
  • Richard Heller and
  • Stephen J. Beebe

27 June 2018

A Pancreatic cancer is a notorious malignant neoplasm with an extremely poor prognosis. Current standard of care is rarely effective against late-stage pancreatic cancer. In this study, we assessed nanopulse stimulation (NPS) as a local treatment for...

  • Review
  • Open Access
143 Citations
13,820 Views
18 Pages

27 June 2018

Bone metastases are frequently the final fate of breast and prostate cancer patients. According to the definition of metastasis as an incurable disease, to date there are no effective treatments for tumor-associated bone metastases and this represent...

  • Review
  • Open Access
97 Citations
10,042 Views
13 Pages

27 June 2018

p53 has functional roles in tumor suppression as a guardian of the genome, surveillant of oncogenic cell transformation, and as recently demonstrated, a regulator of intracellular metabolism. Accumulating evidence has shown that the tumor microenviro...

  • Feature Paper
  • Review
  • Open Access
21 Citations
5,378 Views
15 Pages

Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia

  • Francesco Buccisano,
  • Richard Dillon,
  • Sylvie D. Freeman and
  • Adriano Venditti

26 June 2018

Minimal (or measurable) residual (MRD) disease provides a biomarker of response quality for which there is robust validation in the context of modern intensive treatment for younger patients with Acute Myeloid Leukemia (AML). Nevertheless, it remains...

  • Review
  • Open Access
44 Citations
7,672 Views
19 Pages

Fusogenic Viruses in Oncolytic Immunotherapy

  • Teresa Krabbe and
  • Jennifer Altomonte

26 June 2018

Oncolytic viruses are under intense development and have earned their place among the novel class of cancer immunotherapeutics that are changing the face of cancer therapy. Their ability to specifically infect and efficiently kill tumor cells, while...

  • Case Report
  • Open Access
1 Citations
4,378 Views
15 Pages

25 June 2018

Background: Polycythemia vera (PV) is a clonal myeloid stem cell disease characterized by a growth-factor independent erythroid proliferation with an inherent tendency to transform into overt acute myeloid malignancy. Approximately 95% of the PV pati...

  • Review
  • Open Access
10 Citations
8,709 Views
12 Pages

Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach

  • Alessandro Isidori,
  • Federica Loscocco,
  • Marilena Ciciarello,
  • Giulia Corradi,
  • Mariangela Lecciso,
  • Darina Ocadlikova,
  • Sarah Parisi,
  • Valentina Salvestrini,
  • Sergio Amadori and
  • Giuseppe Visani
  • + 1 author

22 June 2018

Acute myeloid leukemia (AML) is a disease, which mainly affects the elderly population. Unfortunately, the prognosis of patients aged >65 years is dismal, with 1-year overall survival approaching 10% with conventional therapies. The hypothesis of...

  • Review
  • Open Access
19 Citations
6,452 Views
16 Pages

Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach

  • Taichiro Goto,
  • Yosuke Hirotsu,
  • Kenji Amemiya,
  • Hitoshi Mochizuki and
  • Masao Omata

22 June 2018

Advances in innovative technology, including next-generation sequencing, have allowed comprehensive genomic analysis and the elucidation of the genomic aspect of intratumor heterogeneity (ITH). Moreover, models of the evolution of the cancer genome h...

  • Review
  • Open Access
70 Citations
14,405 Views
14 Pages

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers

  • Maria Lina Tornesello,
  • Clorinda Annunziata,
  • Anna Lucia Tornesello,
  • Luigi Buonaguro and
  • Franco Maria Buonaguro

22 June 2018

Viral oncogenesis is a multistep process largely depending on the complex interplay between viruses and host factors. The oncoviruses are capable of subverting the cell signaling machinery and metabolic pathways and exploit them for infection, replic...

of 4

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694